mikehavRx.com News Bytes: $DCTH, $TRA, $POT, $SUPG, $ACCP.OB, $AMLN

Delcath’s Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient’s entire body to the anti-cancer drugs.

Read more »

Diabetes Drug Wins Approval, Helps the Competition

The approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor.

Read more »